AAAAAA

   
Results: 1-16 |
Results: 16
Persistent increase in plasma thrombomodulin in patients with a history oflupus nephritis: Endothelial cell activation markers
Authors: Frijns, R Fijnheer, R Schiel, A Donders, R Sixma, J Derksen, R
Citation: R. Frijns et al., Persistent increase in plasma thrombomodulin in patients with a history oflupus nephritis: Endothelial cell activation markers, J RHEUMATOL, 28(3), 2001, pp. 514-519
Cyclosporine is associated with endothelial dysfunction but not with platelet activation in renal transplantation
Authors: Schrama, YC van Dam, T Fijnheer, R Hene, RJ de Groot, P Rabelink, TJ
Citation: Yc. Schrama et al., Cyclosporine is associated with endothelial dysfunction but not with platelet activation in renal transplantation, NETH J MED, 59(1), 2001, pp. 6-15
Plasma levels of cellular fibronectin in diabetes
Authors: Kanters, SDJM Banga, JD Algra, A Frijns, RCJM Beutler, JJ Fijnheer, R
Citation: Sdjm. Kanters et al., Plasma levels of cellular fibronectin in diabetes, DIABET CARE, 24(2), 2001, pp. 323-327
Antibodies that stop the adrenals in their tracks
Authors: Vlot, AJ van der Molen, AJ Muls, MJ Fijnheer, R
Citation: Aj. Vlot et al., Antibodies that stop the adrenals in their tracks, LANCET, 358(9279), 2001, pp. 382-382
Lupus anticoagulant and history of thrombosis are not associated with persistent endothelial cell activation in systemic lupus erythematosus
Authors: Frijns, CJM Derksen, RHWM De Groot, PG Algra, A Fijnheer, R
Citation: Cjm. Frijns et al., Lupus anticoagulant and history of thrombosis are not associated with persistent endothelial cell activation in systemic lupus erythematosus, CLIN EXP IM, 125(1), 2001, pp. 149-154
Relationship between graft-versus-host disease and graft-versus-leukaemia in partial T cell-depleted bone marrow transplantation
Authors: van der Straaten, HM Fijnheer, R Dekker, AW Nieuwenhuis, HK Verdonck, LF
Citation: Hm. Van Der Straaten et al., Relationship between graft-versus-host disease and graft-versus-leukaemia in partial T cell-depleted bone marrow transplantation, BR J HAEM, 114(1), 2001, pp. 31-35
Elastase mediated fibrinolysis in acute promyelocytic leukemia
Authors: Oudijk, EJD Nieuwenhuis, HK Bos, R Fijnheer, R
Citation: Ejd. Oudijk et al., Elastase mediated fibrinolysis in acute promyelocytic leukemia, THROMB HAEM, 83(6), 2000, pp. 906-908
Reduced activity of TAFI (thrombin-activatable fibrinolysis inhibitor) in acute promyelocytic leukaemia
Authors: Meijers, JCM Oudijk, EJD Mosnier, LO Bos, R Bouma, BN Nieuwenhuis, HK Fijnheer, R
Citation: Jcm. Meijers et al., Reduced activity of TAFI (thrombin-activatable fibrinolysis inhibitor) in acute promyelocytic leukaemia, BR J HAEM, 108(3), 2000, pp. 518-523
Fc gamma receptor polymorphisms in systemic lupus erythematosus - Association with disease and in vivo clearance of immune complexes
Authors: Dijstelbloem, HM Bijl, M Fijnheer, R Scheepers, RHM Oost, WW Jansen, MD Sluiter, WJ Limburg, PC Derksen, RHWM van de Winkel, JGJ Kallenberg, CGM
Citation: Hm. Dijstelbloem et al., Fc gamma receptor polymorphisms in systemic lupus erythematosus - Association with disease and in vivo clearance of immune complexes, ARTH RHEUM, 43(12), 2000, pp. 2793-2800
Homocysteine in inflammatory bowel disease: A risk factor for thromboembolic complications?
Authors: Oldenburg, B Fijnheer, R van der Griend, R vanBerge-Henegouwen, GP Koningsberger, JC
Citation: B. Oldenburg et al., Homocysteine in inflammatory bowel disease: A risk factor for thromboembolic complications?, AM J GASTRO, 95(10), 2000, pp. 2825-2830
Soluble P-selectin in diabetes
Authors: Jilma, B Fijnheer, R Blann, AD
Citation: B. Jilma et al., Soluble P-selectin in diabetes, THROMB HAEM, 81(3), 1999, pp. 474-474
Significance of soluble P-selectin, von Willebrand factor, and other adhesion molecules in hypercholesterolemia and peripheral artery disease
Authors: Blann, AD Lip, GYH Fijnheer, R
Citation: Ad. Blann et al., Significance of soluble P-selectin, von Willebrand factor, and other adhesion molecules in hypercholesterolemia and peripheral artery disease, CIRCULATION, 99(18), 1999, pp. 2478-2478
Activated platelets release two types of membrane vesicles: Microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules
Authors: Heijnen, HFG Schiel, AE Fijnheer, R Geuze, HJ Sixma, JJ
Citation: Hfg. Heijnen et al., Activated platelets release two types of membrane vesicles: Microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules, BLOOD, 94(11), 1999, pp. 3791-3799
von Willebrand factor proteolysis in thrombotic thrombocytopenic purpura -Response
Authors: Fijnheer, R van der Plas, M Huizinga, E Hene, R Sixma, J Verdonck, L
Citation: R. Fijnheer et al., von Willebrand factor proteolysis in thrombotic thrombocytopenic purpura -Response, BLOOD, 94(10), 1999, pp. 3612-3612
von Willebrand factor propeptide in vascular disorders: A tool to distinguish between acute and chronic endothelial cell perturbation
Authors: van Mourik, JA Boertjes, R Huisveld, IA Fijnvandraat, K Pajkrt, D van Genderen, PJJ Fijnheer, R
Citation: Ja. Van Mourik et al., von Willebrand factor propeptide in vascular disorders: A tool to distinguish between acute and chronic endothelial cell perturbation, BLOOD, 94(1), 1999, pp. 179-185
von Willebrand factor proteolysis is deficient in classic, but not in bonemarrow transplantation-associated, thrombotic thrombocytopenic purpura
Authors: van der Plas, RM Schiphorst, ME Huizinga, EG Hene, RJ Verdonck, LF Sixma, JJ Fijnheer, R
Citation: Rm. Van Der Plas et al., von Willebrand factor proteolysis is deficient in classic, but not in bonemarrow transplantation-associated, thrombotic thrombocytopenic purpura, BLOOD, 93(11), 1999, pp. 3798-3802
Risultati: 1-16 |